{"organizations": [], "uuid": "f76e2cee92f2b22b502dd80c9a37b7aaff872542", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-nanostring-and-rikengenesis-announ/brief-nanostring-and-rikengenesis-announce-partnership-to-commercialize-ncounter-based-diagnostic-assays-in-japan-idUSFWN1OY0RH", "country": "US", "domain_rank": 408, "title": "BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-04T13:19:00.000+02:00", "replies_count": 0, "uuid": "f76e2cee92f2b22b502dd80c9a37b7aaff872542"}, "author": "", "url": "https://www.reuters.com/article/brief-nanostring-and-rikengenesis-announ/brief-nanostring-and-rikengenesis-announce-partnership-to-commercialize-ncounter-based-diagnostic-assays-in-japan-idUSFWN1OY0RH", "ord_in_thread": 0, "title": "BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan", "locations": [], "entities": {"persons": [], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "nanostring technologies inc", "sentiment": "none"}, {"name": "ncounter-based diagnostic assays in japan reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 4, 2018 / 11:19 AM / Updated 18 minutes ago BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan Reuters Staff \nJan 4 (Reuters) - Nanostring Technologies Inc: \n* NANOSTRING AND RIKENGENESIS ANNOUNCE PARTNERSHIP TO COMMERCIALIZE NCOUNTER-BASED DIAGNOSTIC ASSAYS IN JAPAN \n* NANOSTRING -‍ UNDER AGREEMENT, CO, RIKEN GENESIS TO COLLABORATE TO REGISTER, OBTAIN REIMBURSEMENT, COMMERCIALIZE COMPANION DIAGNOSTIC ASSAYS IN JAPAN​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-04T13:19:00.000+02:00", "crawled": "2018-01-04T13:49:14.009+02:00", "highlightTitle": ""}